Janney Montgomery Scott’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.5M | Buy |
266,543
+105,617
| +66% | +$19.9M | 0.1% | 209 |
|
|
2026
Q1 | $31.7M | Sell |
160,926
-1,348
| -0.8% | -$260K | 0.08% | 248 |
|
|
2025
Q4 | $29.8M | Buy |
162,274
+4,929
| +3% | +$864K | 0.07% | 276 |
|
|
2025
Q3 | $24.1M | Buy |
157,345
+4,442
| +3% | +$672K | 0.06% | 317 |
|
|
2025
Q2 | $21.4M | Buy |
152,903
+3,748
| +3% | +$525K | 0.06% | 327 |
|
|
2025
Q1 | $21.9M | Buy |
+149,155
| New | +$21.6M | 0.06% | 309 |
|
|
2024
Q4 | – | Sell |
-143,426
| Closed | -$22.3M | – | 2695 |
|
|
2024
Q3 | $22.3M | Buy |
143,426
+1,185
| +0.8% | +$191K | 0.06% | 311 |
|
|
2024
Q2 | $22.2M | Buy |
142,241
+42
| +0% | +$6.32K | 0.07% | 290 |
|
|
2024
Q1 | $19.3M | Buy |
142,199
+11,327
| +9% | +$1.5M | 0.06% | 342 |
|
|
2023
Q4 | $17.6M | Buy |
130,872
+24,626
| +23% | +$3.2M | 0.06% | 334 |
|
|
2023
Q3 | $14.4M | Buy |
106,246
+3,020
| +3% | +$412K | 0.05% | 329 |
|
|
2023
Q2 | $14.8M | Buy |
+103,226
| New | +$15.2M | 0.05% | 343 |
|
|
2023
Q1 | – | Sell |
-94,070
| Closed | -$12.8M | – | 2528 |
|
|
2022
Q4 | $12.8M | Buy |
94,070
+675
| +0.7% | +$84.7K | 0.05% | 352 |
|
|
2022
Q3 | $10.2M | Buy |
+93,395
| New | +$11.8M | 0.04% | 380 |
|
|
2021
Q1 | – | Sell |
-94,919
| Closed | -$9.49M | – | 2223 |
|
|
2020
Q4 | $9.49M | Sell |
94,919
-4,275
| -4% | -$453K | 0.05% | 341 |
|
|
2020
Q3 | $10.9M | Buy |
99,194
+32,631
| +49% | +$3.63M | 0.06% | 279 |
|
|
2020
Q2 | $7.04M | Sell |
66,563
-2,846
| -4% | -$294K | 0.04% | 358 |
|
|
2020
Q1 | $6.2M | Buy |
69,409
+9,358
| +16% | +$881K | 0.05% | 340 |
|
|
2019
Q4 | $5.99M | Sell |
60,051
-52
| -0.1% | -$4.9K | 0.04% | 403 |
|
|
2019
Q3 | $5.36M | Sell |
60,103
-343
| -0.6% | -$29.7K | 0.04% | 412 |
|
|
2019
Q2 | $4.99M | Buy |
60,446
+3,175
| +6% | +$249K | 0.04% | 430 |
|
|
2019
Q1 | $4.63M | Sell |
57,271
-2,122
| -4% | -$167K | 0.04% | 420 |
|
|
2018
Q4 | $4.51M | Sell |
59,393
-1,288
| -2% | -$101K | 0.04% | 389 |
|
|
2018
Q3 | $4.8M | Sell |
60,681
-114,409
| -65% | -$8.65M | 0.04% | 418 |
|
|
2018
Q2 | $12.3M | Sell |
175,090
-1,334
| -0.8% | -$96K | 0.12% | 199 |
|
|
2018
Q1 | $12.3M | Buy |
176,424
+4,801
| +3% | +$333K | 0.12% | 191 |
|
|
2017
Q4 | $11.9M | Buy |
171,623
+18,593
| +12% | +$1.25M | 0.12% | 197 |
|
|
2017
Q3 | $10.4M | Buy |
153,030
+10,511
| +7% | +$664K | 0.12% | 202 |
|
|
2017
Q2 | $9.72M | Buy |
142,519
+1,644
| +1% | +$107K | 0.12% | 201 |
|
|
2017
Q1 | $8.77M | Buy |
140,875
+22,010
| +19% | +$1.28M | 0.12% | 209 |
|
|
2016
Q4 | $6.5M | Sell |
118,865
-19,837
| -14% | -$1.13M | 0.1% | 228 |
|
|
2016
Q3 | $9.12M | Buy |
+138,702
| New | +$9.07M | 0.16% | 150 |
|
|
2016
Q2 | – | Sell |
-51,162
| Closed | -$2.88M | – | 693 |
|
|
2016
Q1 | $2.88M | Buy |
51,162
+18,888
| +59% | +$1.13M | 0.08% | 257 |
|
|
2015
Q4 | $2.19M | Sell |
32,274
-15,546
| -33% | -$1.02M | 0.06% | 324 |
|
|
2015
Q3 | $3.04M | Buy |
47,820
+1,187
| +3% | +$78.1K | 0.09% | 261 |
|
|
2015
Q2 | $2.97M | Buy |
46,633
+550
| +1% | +$37.7K | 0.06% | 368 |
|
|
2015
Q1 | $3.15M | Buy |
46,083
+3,496
| +8% | +$243K | 0.06% | 396 |
|
|
2014
Q4 | $3M | Sell |
42,587
-5,087
| -11% | -$364K | 0.06% | 398 |
|
|
2014
Q3 | $3.41M | Buy |
47,674
+1,349
| +3% | +$98.7K | 0.07% | 351 |
|
|
2014
Q2 | $3.44M | Sell |
46,325
-20,713
| -31% | -$1.5M | 0.08% | 330 |
|
|
2014
Q1 | $4.35M | Buy |
67,038
+11,922
| +22% | +$770K | 0.11% | 237 |
|
|
2013
Q4 | $3.27M | Buy |
55,116
+685
| +1% | +$37.2K | 0.09% | 284 |
|
|
2013
Q3 | $2.83M | Buy |
54,431
+33,896
| +165% | +$1.7M | 0.08% | 298 |
|
|
2013
Q2 | $971K | Buy |
+20,535
| New | +$1.05M | 0.1% | 241 |
|
Other funds holding AZN
EP
IA
Janney Montgomery Scott's AZN Position: Q2 2026 in Review
Janney Montgomery Scott increased its AstraZeneca (AZN) stake by 66% in Q2 2026, buying an estimated $19.9M and bringing the position to 266,543 shares worth $50.5M. The position accounts for 0.1% of the portfolio, ranked #209.
Janney Montgomery Scott first reported a position in AZN in Q2 2013 and has held it in 44 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Janney Montgomery Scott held 266,543 shares of AstraZeneca worth $50.5M as of Q2 2026.
- Janney Montgomery Scott bought 105,617 AstraZeneca shares in Q2 2026, an estimated $19.9M.
- AstraZeneca made up 0.1% of Janney Montgomery Scott's portfolio in Q2 2026, its #209 holding.
- Janney Montgomery Scott first reported a position in AstraZeneca in Q2 2013 and has held it in 44 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.